Trade

Jubilant Ingrevia share price

High risk
  • 48%Low risk
  • 48%Moderate risk
  • 48%Balanced risk
  • 48%High risk
  • 48%Extreme risk
  • 816.65(1.83%)
    July 10, 2025 15:29:44 PM IST
    • NSE
    • BSE
  • Vol : 408.57K (NSE + BSE)
    Last 20 day avg : 2.75 M

Jubilant Ingrevia is trading 1.83% upper at Rs 816.65 as compared to its last closing price. Jubilant Ingrevia has been trading in the price range of 820.55 & 796.50. Jubilant Ingrevia has given -2.60% in this year & 3.63% in the last 5 days. Jubilant Ingrevia has TTM P/E ratio 40.90 as compared to the sector P/E of 22.32.There are 3 analysts who have initiated coverage on Jubilant Ingrevia. There are - analysts who have given it a strong buy rating & - analysts have given it a buy rating. - analysts have given the stock a sell rating.The company posted a net profit of 74.05 Crores in its last quarter.Listed peers of Jubilant Ingrevia include Paradeep Phosphates (0.81%), Anupam Rasayan India (-0.78%), Jubilant Ingrevia (1.83%).The Mutual Fund holding in Jubilant Ingrevia was at 14.10% in 31 Mar 2025. The MF holding has increased from the last quarter. The FII holding in Jubilant Ingrevia was at 7.12% in 31 Mar 2025. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Key Metrics

Updated on Jul 10, 2025, 11:43 AM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.63
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    4.26
    Higher than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    49.77
    Higher than historical values
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    1.16
    High volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.26
    In line with industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
796.50
Highest
820.55
52 week range
Lowest
524.30
Highest
884.95
Jubilant Ingrevia Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    • financial-insightsCompany is profitable
    • financial-insightsThe company's revenue fell during March quarter by 2.16% from Rs 1074.44 crore to Rs 1051.26 crore, year-on-year
    • financial-insightsThe company has grown its March quarter profit by 153.18% from Rs 29.25 crore to Rs 74.05 crore, year-on-year
    • financial-insightsThe debt to equity of the company is higher than the industry median
    • financial-insightsCompany can comfortably pay off its interest obligations with its earnings
Jubilant Ingrevia Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 810.87
  • R2
  • 859.43
  • R3
  • 896.37
Pivot773.93
  • S1
  • 725.37
  • S2
  • 688.43
  • S3
  • 639.87
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Jubilant Ingrevia Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Paradeep Phosphates
Bullish
162.100.8113,245.6824.083.250.3115.65
Anupam Rasayan India
Bullish
1,135.00-0.7812,477.20135.004.430.117.82
Jubilant Ingrevia
Bullish
816.651.8313,034.1049.224.210.6412.58
Alkyl Amines Chemicals
Bullish
2,310.65-0.6811,848.7464.258.540.430.08
Aether Industries
Neutral
779.20-0.1110,331.4359.894.5-0.67
Jubilant Ingrevia Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Jubilant Ingrevia is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPledged found - Promoter(s) have pledged 2.71% of shares.
    • InsightsPledging Flat - Promoter(s) pledging has not increased in last quarter.
    • InsightsPromoter(s) holds a high stake in the company at 51.47%
    • InsightsFIIs are invested in this company
    • InsightsFIIs holding has increased by 0.23 percentage points from previous quarter
    • InsightsMutual Funds holding has increased by 0.19 percentage points from previous quarter
    Mutual Fund Ownership
    View all
    DSP Regular Saving Fund Regular Plan Growth
    3/5
    • Amount Invested (Cr.) 0.60
    • % of AUM 0.34
    ICICI Prudential Regular Savings Fund Growth
    4/5
    • Amount Invested (Cr.) 5.49
    • % of AUM 0.17
    Jubilant Ingrevia Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-05-13Audited Results & Final Dividend
    2025-01-28Quarterly Results & Interim Dividend
    2024-10-22Quarterly Results
    2024-07-16Quarterly Results
    2024-05-14Audited Results & Final Dividend
    About the company Jubilant Ingrevia
    • IndustryChemical Manufacturing
    • ISININE0BY001018
    • BSE Code543271
    • NSE CodeJUBLINGREA
    Jubilant Ingrevia Limited is a vertically integrated provider of life sciences products and solutions. Its segments include Specialty chemicals, Nutrition & Health solutions and Chemical intermediates. The Specialty Chemicals segment includes bio-pyridine & bio-picolines, fine chemicals, agro chemicals, custom development and manufacturing organization, and microbial control solutions. The Nutrition & Health solutions segment includes nutrition and health ingredients and animal and human nutrition health solutions. The Chemical Intermediates segment includes acetyls and specialty ethanol. In agro chemicals, it offers value-added derivatives, derived from specialty building blocks such as pyridine, picoline and diketene derivatives. This sub-segment includes insecticides, herbicides and fungicides. Its product portfolio includes vital nutritional ingredients, including Vitamin B3, Vitamin B4, Picolinates, and premix formulations designed for both animal and human nutrition.
    • Management Info
    • Hari BhartiaExecutive Co-Chairman of the Board
    • Prakash BishtPresident, Chief Financial Officer
    • Deepak JainChief Executive Officer, Managing Director, Executive Director
    • Ambrish DixitPresident - Speciality Chemicals
    • Vijay SrivastavaChief of Operations, Whole-Time Director
    • Vinita KoulSenior Vice President, Head - HR
    • Birajeev SinghSenior Vice President, Head - Supply Chain
    • Deepanjali GulatiCompliance Officer, Company Secretary
    • Himanshu DhapolavSBU Head - Acetyls
    Jubilant Ingrevia Share Price FAQs

    Jubilant Ingrevia is trading at 816.65 as on Thu Jul 10 2025 09:59:44. This is 1.83% upper as compared to its previous closing price of 801.95.

    The market capitalization of Jubilant Ingrevia is 13034.10 Cr as on Thu Jul 10 2025 09:59:44.

    The 52 wk high for Jubilant Ingrevia is 884.95 whereas the 52 wk low is 524.30

    Jubilant Ingrevia can be analyzed on the following key metrics -

    • TTM P/E: 40.90
    • Sector P/E: 22.32
    • Dividend Yield: 0.62%
    • D/E ratio: 0.26

    Jubilant Ingrevia reported a net profit of 251.17 Cr in 2025.

    The Mutual Fund Shareholding was 14.10% at the end of 31 Mar 2025.